FDA Announces Approval of Guidance Document for Automated Blood Cell Separator Devices

Summary

The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) for a guidance document on Class II special controls for automated blood cell separator devices operating by centrifugal or filtration separation principle, as part of the agency's efforts to streamline industry compliance with regulatory requirements.